Mayo Foundation for Medical Education and Research
发明人:
申请号：
EP15830331.3
公开号：
EP3177292A4
申请日:
2015.08.07
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
This document provides compounds, compositions, and methods for treating cancers including renal cancer (e.g., renal cell carcinoma) as well as ovarian, breast, prostate, colon, pancreatic, bladder, liver, lung, and thyroid cancers and melanoma. For example, compounds, compositions, and methods for using one or more inhibitors of SCD1 to treat renal cell carcinoma (e.g., clear cell renal cell carcinoma (ccRCC)), thyroid cancer, or liver cancer； or to increase the efficacy of treatment for the same.
